ArticleJournal of applied clinical medical physics2026

Comparison of in-field secondary cancer risk based on therapeutic proton dose between proton arc therapy and intensity-modulated proton therapy in lung cancer patients.

Yuankang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.